Taken together, these data suggest that ZNF460 and COMMD7 may be therapeutic targets for AML, and we will proceed with in-depth studies on the specific regulatory mechanisms of ZNF460 on COMMD7 and abnormal DNA methylation. Here, COMMD7 is linked to acute myeloid leukemia.